ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 719661 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 719661; 2) Community: the network communities that were significantly associated with the response to NSC 719661; 3) Molecule: the relationships between components within communities and NSC 719661; 4) MDR: the compounds that were significantly associated with the NSC 719661.

NSC Compound Enrichment Correlation
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.00628187335688605 0.50328102
NSC 306911 .beta.-D-Glucopyranose, 2,3-O-(diethylstannylene)- 0.00628187335688605 0.038323553
NSC 604586 2-Butenamide, N-(4-chlorophenyl)-4,4,4-trichloro- 0.00628187335688605 0.35060387
NSC 645809 Null 0.00628187335688605 0.56052399
NSC 670226 trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid 0.00628187335688605 0.14883135
NSC 670284 Null 0.00628187335688605 0.16367817
NSC 740 Methotrexate 0.00628187335688605 0.52578183
NSC 113452 Null 0.00701295499506013 0.40665277
NSC 266046 Oxaliplatin 0.00701295499506013 0.43383338
NSC 510656 Benzonitrile, 2-amino-3,5-dinitro- (9CI) 0.00701295499506013 0.010717746
Total:62  Current:8    [First] [Prev] [Next] [Last]